• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeoGenomics, Inc. - Common Stock (NQ:NEO)

    15.75 -0.13 (-0.82%)
    Streaming Delayed Price Updated: 9:50 AM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 101,257
    Open 15.78
    Bid (Size) 15.70 (200)
    Ask (Size) 15.77 (300)
    Prev. Close 15.88
    Today's Range 15.46 - 15.90
    52wk Range 4.720 - 16.17
    Shares Outstanding 122,816,314
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why NeoGenomics (NEO) Stock Is Up Today
    What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 15.8% in the afternoon session after the company reported seco... 
    Via StockStory
    News headline image
    3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
    Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
    Via StockStory

    Performance

    YTD
    +33.9%
    +33.9%
    1 Month
    +8.0%
    +8.0%
    3 Month
    +70.1%
    +70.1%
    6 Month
    +27.0%
    +27.0%
    1 Year
    +208.8%
    +208.8%

    More News

    Read More
    News headline image
    NeoGenomics Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    NeoGenomics (NASDAQ:NEO): Quality Stock After Q2 Earnings Beat and Raised Guidance ↗
    Via Chartmill
    Topics Earnings
    News headline image
    NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
    Via StockStory
    News headline image
    NeoGenomics Reports Second Quarter 2026 Results
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 Momentum Stock with Solid Fundamentals and 2 We Avoid
    Via StockStory
    News headline image
    NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    3 Small-Cap Stocks with Questionable Fundamentals
    Via StockStory
    News headline image
    NeoGenomics (NEO) Stock Trades Up, Here Is Why
    Via StockStory
    Topics Intellectual Property Lawsuit
    News headline image
    NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
    Via StockStory
    News headline image
    NeoGenomics Appoints Carolyn Starrett to its Board of Directors
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds
    Via StockStory
    News headline image
    NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics to Present New Research at ASCO Annual Meeting 2026
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics to Participate in Upcoming Investor Conferences
    From NeoGenomics, Inc.
    Via Business Wire
    News headline image
    NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    3 Russell 2000 Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    3 Reasons NEO is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Bankruptcy Stocks Supply Chain
    News headline image
    5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    NEO Q1 Deep Dive: High-Value Test Expansion and Commercial Execution Drive Oncology Growth
    Via StockStory

    Frequently Asked Questions

    Is NeoGenomics, Inc. - Common Stock publicly traded?
    Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
    What exchange does NeoGenomics, Inc. - Common Stock trade on?
    NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
    The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
    What is the current price of NeoGenomics, Inc. - Common Stock?
    The current price of NeoGenomics, Inc. - Common Stock is 15.75
    When was NeoGenomics, Inc. - Common Stock last traded?
    The last trade of NeoGenomics, Inc. - Common Stock was at 07/31/26 09:50 AM ET
    What is the market capitalization of NeoGenomics, Inc. - Common Stock?
    The market capitalization of NeoGenomics, Inc. - Common Stock is 1.93B
    How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
    NeoGenomics, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.